NovoCure Ltd

NASDAQ: NVCR
$17.44
-$0.21 (-1.2%)
Closing Price on November 8, 2024

NVCR Stock Chart and Intraday Price

NVCR Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Address NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, JE
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 1,740.26M USD
Shares Outstanding 107,093,000
NovoCure Ltd specializes in innovative cancer treatment technologies, focusing on its unique Tumor Treating Fields (TTFields) devices. These devices, including Optune Gio and Optune Lua, are designed to combat solid tumor cancers across various parts of the world. Beyond manufacturing, NovoCure is deeply involved in clinical trials to expand the use of TTFields in treating multiple cancer types, demonstrating its commitment to advancing cancer care. Founded in 2000, the company is based in Saint Helier, Jersey, marking its global footprint in the fight against cancer.

NVCR Articles

Tuesday's top analyst upgrades and downgrades included Academy Sports and Outdoors, Boston Scientific, Ciena, CrowdStrike, Emerson Electric, Kimco Realty, Nike, NovoCure and Zimmer Biomet.
Wednesday's top analyst upgrades and downgrades included Amazon.com, Beyond Meat, Compass, DraftKings, Genius Sports, Home Depot, International Flavors & Fragrances, Lowe's, Palantir Technologies,...
Monday's top analyst upgrades and downgrades included Amazon.com, Amgen, Apple, BioCryst Pharmaceuticals, Block, Coinbase Global, Datadog, Fortinet, Gilead Sciences, Intercontinental Exchange,...
Tuesday's top analyst upgrades and downgrades included Adobe, Airbnb, Apple, Capri, Carvana, Chevron, Expedia, GE Healthcare Technologies, Hasbro, Monster Beverage, Nutrien, Salesforce, Tencent Music...
Wednesday's top analyst upgrades and downgrades included Amgen, Canadian Pacific Kansas City, Carvana, Coinbase Global, Etsy, First Horizon, GE Healthcare Technologies, Gilead Sciences, Home Depot,...
Monday's top analyst upgrades and downgrades included Alphabet, Bill, Bumble, Dollar General, FedEx, FMC, Jabil Circuit, Microsoft, Nike, Nvidia, Sarepta Therapeutics, Shopify, Synchrony Financial,...
Friday's top analyst upgrades and downgrades included Ally Financial, American Express, AppLovin, AstraZeneca, Coinbase Global, Cognizant Technology Solutions, Comcast, CME, CrowdStrike, Delta Air...
Tuesday's top analyst upgrades and downgrades included Advanced Micro Devices, Analog Devices, Analog Devices, Chevron, Danaher, FedEx, Intel, Meta Platforms, NXP Semiconductors, Qualcomm, Southern,...
Monday's top analyst upgrades and downgrades included AT&T, ADM, Chevron, FedEx, Intel, Meta, Qualcomm and more.
Tuesday's top analyst upgrades and downgrades included Advanced Micro Devices, Block, Bumble, DigitalOcean, Duke Realty, FirstEnergy, HF Sinclair, Nio, Petco Health and Wellness, Roblox, Rocket...
Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, Beyond Meat, Colgate-Palmolive, Edwards Lifesciences, Electronic Arts, Exxon Mobil, Meta Platforms, PayPal and...
Tuesday's top analyst upgrades and downgrades included Broadcom, Carrier Global, Canadian Pacific Railway, Coca-Cola, Eli Lilly, Marvell Technology, Pfizer, Regions Financial, Stryker, Synchrony...
24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including NovoCure, Synchrony, Twitter and Yum! Brands.
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk...